PL3615015T3 - Zmiatacze gamma-ketoaldehydu do leczenia miażdżycy - Google Patents

Zmiatacze gamma-ketoaldehydu do leczenia miażdżycy

Info

Publication number
PL3615015T3
PL3615015T3 PL18724734.1T PL18724734T PL3615015T3 PL 3615015 T3 PL3615015 T3 PL 3615015T3 PL 18724734 T PL18724734 T PL 18724734T PL 3615015 T3 PL3615015 T3 PL 3615015T3
Authority
PL
Poland
Prior art keywords
gamma
treating atherosclerosis
ketoaldehyde
scavengers
ketoaldehyde scavengers
Prior art date
Application number
PL18724734.1T
Other languages
English (en)
Inventor
MacRae LINTON
John A. Oates
Sean S. DAVIES
L. Jackson ROBERTS II
Venkataraman Amarnath
Patricia YANCEY
Huan TAO
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of PL3615015T3 publication Critical patent/PL3615015T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL18724734.1T 2017-04-27 2018-04-27 Zmiatacze gamma-ketoaldehydu do leczenia miażdżycy PL3615015T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762491225P 2017-04-27 2017-04-27
PCT/US2018/029999 WO2018201074A1 (en) 2017-04-27 2018-04-27 Methods for treating atherosclerosis with gamma-ketoaldehyde scavengers

Publications (1)

Publication Number Publication Date
PL3615015T3 true PL3615015T3 (pl) 2024-07-08

Family

ID=62165710

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18724734.1T PL3615015T3 (pl) 2017-04-27 2018-04-27 Zmiatacze gamma-ketoaldehydu do leczenia miażdżycy

Country Status (11)

Country Link
US (1) US11389414B2 (pl)
EP (1) EP3615015B1 (pl)
JP (2) JP2020517721A (pl)
CN (1) CN110799182B (pl)
AU (1) AU2018256890B2 (pl)
CA (1) CA3061486C (pl)
ES (1) ES2984402T3 (pl)
HU (1) HUE066390T2 (pl)
MX (1) MX2019012659A (pl)
PL (1) PL3615015T3 (pl)
WO (1) WO2018201074A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3615015T3 (pl) 2017-04-27 2024-07-08 Vanderbilt University Zmiatacze gamma-ketoaldehydu do leczenia miażdżycy
US20220162240A1 (en) * 2019-01-25 2022-05-26 Vanderbilt University Mitochondria-targeted isoketal/isolevuglandin scavengers
CN113939342A (zh) * 2019-01-25 2022-01-14 Mti生物技术公司 连接三苯基膦鎓的水杨胺衍生物
EP4157243A4 (en) * 2020-06-01 2024-06-12 Vanderbilt University USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021516A2 (en) * 1998-10-14 2000-04-20 Kansas University Medical Center Research Institute, Inc. Methods for inhibiting diabetic complications
WO2002036109A2 (en) * 2000-11-02 2002-05-10 University Of South Carolina Use of pyridoxamine for the treatment and inhibition of obesity-related complications
ITRM20010464A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
US8822542B2 (en) * 2004-10-20 2014-09-02 Vanderbilt University Isoketal scavengers and mitigation of disorders involving oxidative injury
WO2011008202A1 (en) * 2009-07-15 2011-01-20 Vanderbilt University Isoketal scavengers and mitigation of disorders involving oxidative injury
JP6280033B2 (ja) 2011-07-12 2018-02-14 ヴァンダービルト ユニバーシティーＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ ガンマ−ケトアルデヒド捕捉剤による炎症および高血圧の治療方法
JP2014052491A (ja) 2012-09-06 2014-03-20 Nikon Corp 焦点調節装置
KR20160036568A (ko) * 2013-07-18 2016-04-04 노파르티스 아게 보체 인자 d 억제제로서의 아미노메틸-비아릴 유도체 및 그의 용도
CN109689619A (zh) * 2016-07-06 2019-04-26 范德比尔特大学 使用反应性γ-酮醛的清除剂以延长细胞寿命和健康期限
AU2017324935B2 (en) * 2016-09-06 2021-10-21 Mti Biotech, Inc. Compositions and methods of use of gamma-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver
PL3615015T3 (pl) 2017-04-27 2024-07-08 Vanderbilt University Zmiatacze gamma-ketoaldehydu do leczenia miażdżycy

Also Published As

Publication number Publication date
EP3615015B1 (en) 2024-03-13
JP7236764B2 (ja) 2023-03-10
HUE066390T2 (hu) 2024-07-28
MX2019012659A (es) 2020-07-24
US11389414B2 (en) 2022-07-19
ES2984402T3 (es) 2024-10-29
EP3615015C0 (en) 2024-03-13
WO2018201074A1 (en) 2018-11-01
US20200138747A1 (en) 2020-05-07
JP2022046654A (ja) 2022-03-23
AU2018256890B2 (en) 2024-04-11
EP3615015A1 (en) 2020-03-04
AU2018256890A1 (en) 2019-11-14
BR112019022523A2 (pt) 2020-05-12
JP2020517721A (ja) 2020-06-18
CA3061486C (en) 2022-08-30
CN110799182A (zh) 2020-02-14
CA3061486A1 (en) 2018-11-01
CN110799182B (zh) 2024-02-20

Similar Documents

Publication Publication Date Title
ZA201706616B (en) Method for treating cancer
SG10201913085TA (en) Methods and compositions for treating a serpinc1-associated disorder
IL249600A0 (en) Bone marrow cell transplant treatment
IL254393A0 (en) Methods for treating diseases associated with pathological changes in protein
GB2558326B (en) Methods and compositions for inhibiting and treating neurological conditions
IL256243B (en) Methods and preparations for treating conditions related to aging
IL257691A (en) A method for treating cancer
SI3368466T1 (sl) Naprava za obdelavo vsebnikov
IL258988A (en) Methods for treating epilepsy
PT3304501T (pt) Procedimento para controlo electrónico de acesso
IL287983A (en) 15-hepe or a preparation containing 15-hepe for the treatment or prevention of fibrosis
GB201709403D0 (en) Compounds for treating sarcoma
PL3186013T3 (pl) Urządzenie do obróbki przedmiotów
GB201701906D0 (en) Processing method
PL2913284T3 (pl) Sposób oraz urządzenie do obróbki części
EP3194025A4 (en) Methods for preventing or treating osteoarthritis
HUE066390T2 (hu) Eljárások ateroszklerózis kezelésére gamma-ketoaldehid-szkevendzserekkel
SG10201508795XA (en) Method for treating cancer
SG11202003127WA (en) Methods for treating lymphomas
GB201709540D0 (en) Processing method
PT3250218T (pt) Péptido natkide para o tratamento da obesidade
GB201502201D0 (en) Plant processing apparatus
GB201715139D0 (en) Security Method
LT3286198T (lt) Junginiai, skirti gydyti niežulio būkles
EP3159292B1 (en) CANVAS TREATMENT APPARATUS